Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News BioTheryX begins BTX-A51 phase 1 trial in AML and myelodysplastic syndrome BTX-A51 phase 1 trial : US biotech company BioTheryX has initiated patient dosing in its first clinical program… bypharmanewsdailyJanuary 19, 2020